Inventor

NAMDOO KIM

Inventor

Overview

3→

Patents

2025

Patent span

Human necessities

Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%

C07DHeterocyclic compounds38%

A61KPreparations for medical, dental or toiletry purposes13%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%

PatentTitleYear

12,479,847Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK22025 12,275,731Azaindole inhibitors of wild-type and mutant forms of LRRK22025 12,240,844Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025Patents assigned to VORONOI INC (3)· patent assignee history

2025Patents assigned to DANA FARBER CANCER INST INC (2)· patent assignee history

2025Based in KR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
VORONOI INC	3	2025
DANA FARBER CANCER INST INC	2	2025

Locations

Location	Patents	Span
KR	3	2025